These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 34963452

  • 1. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y.
    Microb Cell Fact; 2021 Dec 28; 20(1):233. PubMed ID: 34963452
    [Abstract] [Full Text] [Related]

  • 2. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M.
    J Affect Disord; 2018 Aug 01; 235():506-512. PubMed ID: 29684865
    [Abstract] [Full Text] [Related]

  • 3. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA.
    Scand J Gastroenterol; 2019 Jun 01; 54(6):690-699. PubMed ID: 31190584
    [Abstract] [Full Text] [Related]

  • 4. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T.
    PLoS One; 2018 Jun 01; 13(11):e0194904. PubMed ID: 30427836
    [Abstract] [Full Text] [Related]

  • 5. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M, Valeur J, Hausken T, Gunnar Hatlebakk J.
    Neurogastroenterol Motil; 2021 Feb 01; 33(2):e13983. PubMed ID: 32945066
    [Abstract] [Full Text] [Related]

  • 6. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.
    Guo Q, Lin H, Chen P, Tan S, Wen Z, Lin L, He J, Wen J, Lu S.
    Bioengineered; 2021 Dec 01; 12(2):11885-11897. PubMed ID: 34923901
    [Abstract] [Full Text] [Related]

  • 7. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ.
    J Dig Dis; 2019 Aug 01; 20(8):401-408. PubMed ID: 31070838
    [Abstract] [Full Text] [Related]

  • 8. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T.
    Digestion; 2017 Aug 01; 96(1):29-38. PubMed ID: 28628918
    [Abstract] [Full Text] [Related]

  • 9. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
    Huang HL, Zhu JQ, Yang LS, Wu Q, Shou DW, Chen HT, Ma J, Li YQ, Xu HM, Zhou YJ.
    Oxid Med Cell Longev; 2022 Aug 01; 2022():5121496. PubMed ID: 36187337
    [Abstract] [Full Text] [Related]

  • 10. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E, Lorentz A.
    J Appl Microbiol; 2023 Mar 01; 134(3):. PubMed ID: 36882216
    [Abstract] [Full Text] [Related]

  • 11. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG.
    World J Gastroenterol; 2021 May 14; 27(18):2219-2237. PubMed ID: 34025075
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
    Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P.
    Aliment Pharmacol Ther; 2020 Jun 14; 51(12):1321-1331. PubMed ID: 32343000
    [Abstract] [Full Text] [Related]

  • 13. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Singh P, Alm EJ, Kelley JM, Cheng V, Smith M, Kassam Z, Nee J, Iturrino J, Lembo A.
    Gut Microbes; 2022 Jun 14; 14(1):2020067. PubMed ID: 35014601
    [Abstract] [Full Text] [Related]

  • 14. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T, Joossens M, Vázquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D.
    Gastroenterology; 2021 Jan 14; 160(1):145-157.e8. PubMed ID: 32681922
    [Abstract] [Full Text] [Related]

  • 15. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ.
    Lancet Gastroenterol Hepatol; 2019 Sep 14; 4(9):675-685. PubMed ID: 31326345
    [Abstract] [Full Text] [Related]

  • 16. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD, Cold F, Petersen AM, Halkjær SI, Christensen AH, Günther S, Hestbjerg Hansen L.
    Gut Microbes; 2021 Sep 14; 13(1):1-16. PubMed ID: 34074214
    [Abstract] [Full Text] [Related]

  • 17. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hansen LH, Petersen AM.
    Gut; 2018 Dec 14; 67(12):2107-2115. PubMed ID: 29980607
    [Abstract] [Full Text] [Related]

  • 18. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Mazzawi T, El-Salhy M, Lied GA, Hausken T.
    Front Cell Infect Microbiol; 2021 Dec 14; 11():524851. PubMed ID: 34055657
    [Abstract] [Full Text] [Related]

  • 19. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M, Sawada T, Yamamura T, Maeda K, Mizutani Y, Ishikawa E, Furune S, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Nakamura M, Fujishiro M.
    BMC Gastroenterol; 2022 Jul 14; 22(1):342. PubMed ID: 35836115
    [Abstract] [Full Text] [Related]

  • 20. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG.
    Scand J Gastroenterol; 2022 Sep 14; 57(9):1036-1045. PubMed ID: 35486073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.